Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
925
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
-336K
-
Total reported value, excl. options
-
$25.7B
-
Value change
-
-$117M
-
Put/Call ratio
-
1.16
-
Number of buys
-
376
-
Number of sells
-
-497
-
Price
-
$210.60
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2022
1,141 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q1 2022.
BIOGEN INC. - Common Stock (BIIB) has 925 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 147M outstanding shares and own 82.99% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.8M shares), BlackRock Inc. (14.1M shares), VANGUARD GROUP INC (11.7M shares), STATE STREET CORP (7.21M shares), WELLINGTON MANAGEMENT GROUP LLP (6.25M shares), GEODE CAPITAL MANAGEMENT, LLC (2.81M shares), Clearbridge Investments, LLC (2.51M shares), JPMORGAN CHASE & CO (2.18M shares), NORTHERN TRUST CORP (1.69M shares), and Legal & General Group Plc (1.44M shares).
This table shows the top 925 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.